Lanean...
Ligand binding mode prediction by docking: Mdm2/Mdmx inhibitors as a case study
The p53-binding domains of Mdm2 and Mdmx, two negative regulators of the tumor suppressor, p53, are validated targets for cancer therapeutics, but correct binding poses of some proven inhibitors, particularly the nutlins, have been difficult to obtain with standard docking procedures. Virtual screen...
Gorde:
| Argitaratua izan da: | J Chem Inf Model |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4753531/ https://ncbi.nlm.nih.gov/pubmed/24358984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ci4004656 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|